Search
forLearn
5 / 801 resultslearn Selenium sulfide
learn SDA 40
learn Biotinyl-GHK
learn Ganiashi
Research
5 / 54 resultsresearch OR09-5 Importance of Islet Intracrinology for Glucose-Stimulated Insulin Secretion (GSIS) in the Male
Androgens and estrogens are crucial for insulin secretion in males.
research Psychological assessment in 355 Chinese college students with androgenetic alopecia
Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.
research Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.
research Mental status in patients with different forms of diffuse alopecia: analysis of the spectrum and expression of psychopathological symptoms
Women with mixed alopecia have more severe mental health issues than those with metabolic alopecia.
research Wound Healing Efficacy of Cellulose Hydrogel on ICR Mice: A Morphoanatomical, Histological and Genomic Study
NIMO-CH hydrogel effectively heals wounds with minimal scarring and promotes hair growth.
Community Join
5 / 1000+ resultscommunity My progress story for my hair loss treatment
User's hair loss treatment progress includes 1 mg finasteride, 2.5 mg minoxidil tablets twice daily, microneedling 3 times a week, and Fungoral shampoo twice weekly. Good progress and minimal side effects reported.
community DIY Dutasteride Mesotherapy....THE ULTIMATE EXPERIMENT WITH RESULTS!
User tried DIY Dutasteride Mesotherapy for hair loss due to unsatisfactory Finasteride results. Used mesotherapy injection gun and liquid dutasteride for better results and fewer side effects.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community GT20029 - Promising phase II results
GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.
community Estimate of GT20029 on the grey market?
The conversation is about when GT20029, a hair loss treatment, might be available on the grey market, with users discussing the challenges of compounding it and speculating it might be available after phase 2 results, similar to pyri. Specific treatments mentioned are pyri, RU58841, and GT20029.